Cancer Care > Hematology Oncology

Hematology Oncology

Why choose Wayne Health for Hematology Oncology?

Wayne Health’s Malignant Hematology Team takes a comprehensive, multidisciplinary approach to diagnosing, treating and researching hematologic malignancies including leukemia, lymphoma and multiple myeloma.

Members of the team include board-certified hematologists and medical oncologists, as well as a radiation oncologist, pathologist and cytogeneticist. The team works closely with the Karmanos Cancer Institute’s Stem Cell and Bone Marrow Transplant team. By working together, we combine the experience and knowledge of expert clinicians from several different fields to give our patients the best information, a thorough diagnosis and most effective treatments based on individual needs.

Hematology Oncology services offered

  • Leukemia
  • Lymphoma
  • Multiple Myeloma

Overview

Leukemia: Overview

Lymphoma

A lymphoma is a type of cancer that affects the lymph system, which is part of the body’s immune system. The two main types of lymphoma are Hodgkin lymphoma and non-Hodgkin lymphoma.

Lymphomas are more common in men than in women. In most cases the cause is not known. Symptoms of lymphoma include swelling in one or more groups of lymph nodes, weakness, fever, weight loss, and an enlarged liver and spleen.

Depending on the type of lymphoma and whether it is confined to a single group of lymph nodes or affects many lymph nodes, treatment may include radiation therapy, chemotherapy, targeted therapy, or a stem cell transplant.

Risk Factors

What increases your risk of getting leukemia?

Some things can increase your chances of getting leukemia. These things are called risk factors. But many people who get leukemia don’t have any of these risk factors. And some people who have risk factors don’t get this cancer.

General risk factors for leukemia

  • Exposure to high levels of radiation
  • Chemotherapy or radiation used to treat a previous cancer
  • Conditions caused by abnormal chromosomes, such as Down syndrome

Other risk factors for AML

  • Exposure to chemicals, such as benzene and formaldehyde

Other risk factors for CLL

  • Your family history. In some cases, CLL runs in families
  • Being middle-aged or older, male, and white
  • Being infected with a virus known as HTLV-1

Other risk factors for CML

Having a gene change (mutation) called the Philadelphia chromosome.

What causes multiple myeloma?

Our approach to treatment

On the day of your appointment, you will meet with the appropriate Malignant Hematology Team members. A team of physicians evaluates each of our patients, reviews all records, requests any needed additional testing, and discusses the information at a multidisciplinary team conference. After the team conference, a physician shares the team’s recommendations with you and your family members. If other testing is required, or if other specialists need to be seen as part of the proposed therapy, those appointments are arranged the same day or as soon as it is  convenient for the patient.

Support groups and screenings

Karmanos Cancer Institute offers the following support groups for cancer patients and their families:

·     Women Achieving Victory & Esteem is a monthly support group for female cancer patients (any type, any stage).

·     Latina Cancer Support Group/Unidas En Victoria Contra El Cancer meets twice a month and is a support group for Spanish-speaking women with cancer. Location/Sítio: Most Holy Redeemer Church, 1721 Junction St., Detroit, MI 48209.

·     Brothers Reaching & Achieving Victory & Esteem is a monthly support group for male cancer patients (any type, any stage).

How is leukemia treated?

Treatment for leukemia is based on the type of leukemia, whether it has spread, and other things such as your overall health. Treatment options may include:

Chemotherapy and other medicines.

Chemotherapy medicines kill fast-growing cells, including cancer cells and some normal cells.

Other medicines may be given to help chemotherapy work better and prevent infection or bleeding. Examples include steroids and antibiotics.

Radiation therapy.

This uses high-dose X-rays to destroy cancer cells and shrink tumors.

Stem cell transplant.

This replaces damaged cells with healthy stem cells. They help your bone marrow make healthy blood cells.

Targeted therapy.

These medicines attack only cancer cells, not normal cells. They help keep cancer from growing or spreading.

Immunotherapy.

This treatment helps your immune system fight cancer. It may be given in several ways.

Sometimes a clinical trial may be a good choice.

Your doctor will talk with you about your options and then make a treatment plan.

How is multiple myeloma treated?

Multiple myeloma that isn’t causing symptoms may not need treatment right away. If you need treatment, it may include:

Chemotherapy.

These medicines kill fast-growing cells like cancer cells.

Radiation therapy.

This uses high-dose X-rays to destroy cancer cells and shrink tumors.

Steroid medicines.

These can help treat myeloma and help with treatment side effects, such as pain and swelling.

Targeted therapy.

These medicines attack only cancer cells, not normal cells. They help keep cancer from growing or spreading.

Stem cell transplants.

This replaces damaged cells with healthy stem cells. They help your bone marrow make healthy blood cells.

Immunotherapy.

This treatment helps your immune system fight cancer. It may be given in several ways.

Bone-modifying agents.

These medicines make bones stronger. This helps prevent fractures and reduces bone pain.

Bone tumors caused by multiple myeloma may be treated with medicines, radiation, and surgery

Advancing research and medical education

Physicians and researchers at Wayne Health are also faculty members of the Wayne State University School of Medicine who partner with Karmanos Cancer Institute to conduct research and clinical studies. This makes the latest treatments and clinical trials available to you sooner than other health providers without a medical school affiliation.

The Hematology Oncology team’s research focuses on the development of new medication therapies for chronic myelogenous leukemia, multiple myeloma, MDS and acute leukemia. Through the work of the Malignant Hematology Oncology Team, we were one of the first in the nation to offer Gleevec, an oral chemotherapy medication for certain types of leukemia, during clinical research trials.

For more information, please visit the links below at the WSU School of Medicine.

Meet our doctors/providers